HomeCOLOB • SWX
add
Coloplast A/S
Previous close
CHF 109.85
Year range
CHF 109.85 - CHF 109.85
Market cap
129.57B DKK
P/E ratio
-
Dividend yield
-
Primary exchange
CPH
Market news
Financials
Income Statement
Revenue
Net income
(DKK) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 6.96B | 1.06% |
Operating expense | 2.79B | 0.43% |
Net income | 805.00M | -36.81% |
Net profit margin | 11.57 | -37.46% |
Earnings per share | 4.93 | -14.85% |
EBITDA | 2.26B | 2.73% |
Effective tax rate | 40.01% | — |
Balance Sheet
Total assets
Total liabilities
(DKK) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 726.00M | -18.15% |
Total assets | 47.88B | -1.44% |
Total liabilities | 31.43B | -1.95% |
Total equity | 16.45B | — |
Shares outstanding | 225.17M | — |
Price to book | 1.50 | — |
Return on assets | 9.87% | — |
Return on capital | 11.70% | — |
Cash Flow
Net change in cash
(DKK) | Jun 2025info | Y/Y change |
---|---|---|
Net income | 805.00M | -36.81% |
Cash from operations | 1.63B | 9.46% |
Cash from investing | -419.00M | -19.71% |
Cash from financing | -1.18B | -3.32% |
Net change in cash | -3.00M | -50.00% |
Free cash flow | 352.50M | -57.98% |
About
Coloplast A/S is a Danish multinational company that develops, manufactures and markets medical devices and services related to ostomy, urology, continence, and wound care. Wikipedia
Founded
1957
Headquarters
Website
Employees
16,814